This project aims to determine the efficacy of our palbociclib-bortezomib clinical trial in mantle cell lymphoma, based on preclinical studies that have shown enhanced killing of MCL and myeloma cells
Precision medicine is associated with favorable outcomes in selected patients with cancer. Herein, we report an interim analysis of IMPACT2, an ongoing randomized study evaluating genomic profiling an
